---
schema_version: "secwatch.filing_event.v1"
accession: "0001213900-25-125299"
form_type: "8-K"
ticker: "CPHI"
cik: "0001106644"
company_name: "CHINA PHARMA HOLDINGS, INC."
filed_at: "2025-12-23T23:59:59+00:00"
generated_at: "2026-05-16T12:13:28.737208+00:00"
event_type: "m_and_a"
sentiment: "positive"
materiality_score: 0.6
calibrated_materiality_score: 0.6
confidence: "high"
source: SEC EDGAR
---

# China Pharma subsidiary acquires Ipragliflozin patent for $9.8M in stock

## Summary
- Hainan Helpson enters Technology Transfer Agreement to acquire Ipragliflozin tablet patent from Juan Zhang.
- Total consideration: $9.8 million paid in 7,000,000 restricted CPHI shares at $1.40 per share.
- Transferor to provide technical services including product R&D, registration materials, and application.
- Shares issued under Regulation S to non-U.S. person, unregistered and exempt from Securities Act registration.

## SEC filing metadata
- accession: 0001213900-25-125299
- form_type: 8-K
- ticker: CPHI
- cik: 0001106644
- company_name: CHINA PHARMA HOLDINGS, INC.
- filed_at: 2025-12-23T23:59:59+00:00
- event_type: m_and_a
- sentiment: positive
- materiality_score: 0.6
- calibrated_materiality_score: 0.6
- confidence: high
- sec_items: 1.01, 3.02
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1106644/000121390025125299/0001213900-25-125299-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1106644/000121390025125299/ea0270909-8k_chinapharm.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001213900-25-125299
- JSON: https://secwatch.observer/filing/0001213900-25-125299.json
- Plain text: https://secwatch.observer/filing/0001213900-25-125299.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.